Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows Post author: Post published:June 4, 2024 Post category:uncategorized Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells. You Might Also Like Comprehensive analysis of more than 2 million SARS-CoV-2 samples detects co-infections and intra-host recombination January 17, 2024 Potential new mRNA-based therapy for pre-eclampsia December 13, 2024 FDA-approved osteoporosis drug may treat rare genetic heart disease February 18, 2025
Comprehensive analysis of more than 2 million SARS-CoV-2 samples detects co-infections and intra-host recombination January 17, 2024